What the Entresto TV commercial - The Beat Goes On: Healthier Heart is about.
Title: Entresto TV Spot: 'The Beat Goes On: Healthier Heart'
: "Life is full of moments that take our breath away."
: "But for some, those moments can be overshadowed by a serious health condition."
: "John was diagnosed with heart failure, a condition that affects over 26 million people worldwide."
: "Entresto is a prescription medication that helps improve heart function and reduce the risk of hospitalization for heart failure."
: "With Entresto, John regained control over his life. They embraced the moments that mattered most to them."
: "Entresto gave John a chance to live a healthier life, ensuring that 'the beat goes on' for his heart."
: "If you or a loved one are living with heart failure, talk to your doctor about Entresto, because every heartbeat matters."
: "Entresto: Helping you take charge of your heart health and embrace a brighter future."
[End of the TV spot.]
Entresto TV commercial - The Beat Goes On: Healthier Heart produced for
Entresto
was first shown on television on April 9, 2020.
Frequently Asked Questions about entresto tv spot, 'the beat goes on: healthier heart'
How much can Entresto increase your ejection fraction? The PROVE-HF trial showed a median increase in left ventricular ejection fraction from 28.2% to 37.8% at 12 months. A significant 5.2% increase was seen in 6 months.
If your doctor recommends it, you can abruptly stop taking this drug. Doing so isn't known to cause problems. However, keep in mind that symptoms of the condition Entresto was treating may come back if the treatment is stopped. So your doctor will likely recommend another treatment to replace Entresto.
This helps to supply more blood and oxygen to your body. Entresto is recommended in heart treatment guidelines to reduce the risk of cardiovascular death and hospitalization for heart failure in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction.
Common side effects include: dizziness, fainting, light-headedness, cough, headache, diarrhoea, feeling sick, stomach pain, tiredness, weakness. Serious side effects include: swelling of the face, lips, tongue and/or throat and difficulty breathing and/or swallowing.
Researchers from Brigham and Women's Hospital found that heart failure patients with reduced ejection fraction treated with Entresto (sacubitril-valsartan) have a projected increased life expectancy of one and a half to two years, as compared to those treated with Vasotec (enalapril), the current standard of care in ...
They compared Entresto to the ACE-inhibitor enalapril and found Entresto was associated with more than a year longer average survival time, and that it was cost-effective compared to enalapril when these medications were used with other standard of care therapies.
Researchers from Brigham and Women's Hospital found that heart failure patients with reduced ejection fraction treated with Entresto (sacubitril-valsartan) have a projected increased life expectancy of one and a half to two years, as compared to those treated with Vasotec (enalapril), the current standard of care in ...
In addition, Entresto is also approved to treat a certain type of heart failure in children ages 1 year and older. If Entresto works to treat your condition, your doctor will likely recommend that you take it long term.
Researchers from Brigham and Women's Hospital found that heart failure patients with reduced ejection fraction treated with Entresto (sacubitril-valsartan) have a projected increased life expectancy of one and a half to two years, as compared to those treated with Vasotec (enalapril), the current standard of care in ...
If Entresto works to treat your condition, your doctor will likely recommend that you take it long term. Here are some fast facts about Entresto: Active ingredient: sacubitril/valsartan.
In general, about half of all people diagnosed with congestive heart failure will survive 5 years. About 30% will survive for 10 years. In patients who receive a heart transplant, about 21% of patients are alive 20 years later.
In general, about half of all people diagnosed with congestive heart failure will survive 5 years. About 30% will survive for 10 years. In patients who receive a heart transplant, about 21% of patients are alive 20 years later.
